{"name":"Otsuka Pharmaceutical, Inc., Philippines","slug":"otsuka-pharmaceutical-inc-philippines","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Rebamipide and Esomeprazole","genericName":"Rebamipide and Esomeprazole","slug":"rebamipide-and-esomeprazole","indication":"Gastric ulcer","status":"marketed"}]}],"pipeline":[{"name":"Rebamipide and Esomeprazole","genericName":"Rebamipide and Esomeprazole","slug":"rebamipide-and-esomeprazole","phase":"marketed","mechanism":"This combination product uses rebamipide to protect and promote gastric mucosa healing while esomeprazole reduces gastric acid secretion to treat acid-related disorders.","indications":["Gastric ulcer","Duodenal ulcer","Gastroesophageal reflux disease (GERD)","Gastritis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxPY3JVRTFOODNaWExGN1N2OGFMZHFVTGJSYXpkM28xU01Sb29qVFY2YVJnOFB1TGlGMVdKNkhtY3dyQV8yZHJmZ29MckFNcVZPWUxtSjRoNFB5WmlRM3IwZzZXZm94ZlBCTFBTeEJ4U2dpR3JDbnF1d3NmLXRyZjJuYTlRNkNvZFFUelpfT1J3X25lUmZxYVZrV0I4ZDNUMklYNUd4azlJWEpKNmhiV2VvOEN6c05PUjF5WkFFNWE3aWY0cXBuVFhOQm5Ka3NET0hzdC1ibmxZQUZFTEpOak9FTHhPeURQazVuTC11VnI5NFYzVUdULVg4WTFB?oc=5","date":"2026-02-13","type":"regulatory","source":"scanx.trade","summary":"Aurobindo Pharma's Subsidiary Acrotech Receives FDA Approval for ADQUEY Ointment for Atopic Dermatitis Treatment - scanx.trade","headline":"Aurobindo Pharma's Subsidiary Acrotech Receives FDA Approval for ADQUEY Ointment for Atopic Dermatitis Treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFBNa2N1aWd4WTNWZUNqeVJObWJTRWZfai1mV2ZxT2ktREZna3hLMUhQRFRHMHdVVER5SzhVM2pIQ3hSME96UHBreDJvNzBIc3hKcTE4eXdLVEpFMXpvaWlsajRoLWlBQnZTNS1qUGRCYlNGQQ?oc=5","date":"2025-09-22","type":"pipeline","source":"NutraIngredients.com","summary":"Japan focus: Suntory, Meiji, Otsuka Pharma and more - NutraIngredients.com","headline":"Japan focus: Suntory, Meiji, Otsuka Pharma and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxObVo0bDNaeVB1N0dSNzBKa2JzZkwyT18wdTNJd0Y0azBZRmVwUGs1MEh2bGIzdjdiUmpWUDIzV2EwR0pJM2VVTnR5czJ0U0RfYWFYM1ZTVjVFbE8wbXNjNkFJSmFWNUJWbjM4b0JsUGhlekZWaGdZVk14dFZoelEwcVBVTENTM2FJdUdUY1I1UVJJcFFUOHZrVkpESXotWWM3VUxkNTRSb204MXNZN191V2dsSHRDazhlUllJ?oc=5","date":"2025-09-09","type":"pipeline","source":"Fierce Pharma","summary":"Lundbeck, in major resource reallocation, bows out of 27 markets and lays off 602 staffers - Fierce Pharma","headline":"Lundbeck, in major resource reallocation, bows out of 27 markets and lays off 602 staffers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQN2RvLVYyNG1YYmN5MzdyMUtIOTFDQzVxdHl3SlVsdkJzSm00Z1JBMlVYeTJYaXFpa05zODFpQUZHY2MyeFhsTFJIUDNheVJTNndfOTJZU2hSNU56VHVUN085b1NzNWlTY0VPLS1JTmIwanRuZ0dkQkd1aDkySFNTX0dDYVpjdXRtcEJ3bmRHVUYzblBpUWdRWTdsSlVSeGZzcG12OFlqX0Q3aEwyR2x1ZA?oc=5","date":"2025-08-18","type":"pipeline","source":"NutraIngredients.com","summary":"Otsuka Pharma grows electrolyte drink business across Asia - NutraIngredients.com","headline":"Otsuka Pharma grows electrolyte drink business across Asia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE5yRHRKb01DRVY3N05vVlZsLXNCMWN3azJiNWU1YzBES1lMNHI3Y0ZBUDM3MGxOSmpJMEJuV0lENVAxcENfVFE3WFRHS3NCWUttNnV5X2plNm9nTTlhZFVyMzlxYVJ3Qzh5MnBkUVJGdVNQZmlU?oc=5","date":"2025-05-09","type":"pipeline","source":"Law.asia","summary":"Top Japanese firms steer USD1.1bn Japan pharma takeover - Law.asia","headline":"Top Japanese firms steer USD1.1bn Japan pharma takeover","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOTWdtQ2dFSExCaVB5NnFnbllWNE54Y0JlTmNjcHJTSFRHNnE5cER1VVZSdERUWTJWd2xZM2NPblQtbGRSRHNWZDN0Zkp2MWxFN1VqRmR2ckpVTHF6QWZNVDV1Z3BjVWtJWkxfeURCZ2FWNmVmQnNjWTB0a2JtTllQYmxLMjVveDNXd2pkZlFpS2tKTkhRVUJSVGswcUI5TzBGSHhMUnRR?oc=5","date":"2025-01-16","type":"trial","source":"NTT Data","summary":"Streamlined Shipment Inspections at Otsuka Pharma - NTT Data","headline":"Streamlined Shipment Inspections at Otsuka Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxNTGJDaWxXY05HbFdIT0ZyeXhGUElYZ21PVkdaMnYtWWtQTGxSeDNJenlUc0hwNzlzQWZQVmUxaHg0S2FnN0VpRFY4MzZJa1JkbERwdVBFenM3V2NweVljcThycTFJSnBGLTU1dElueHE2alZwZ2M2cEhEcFRrbFQzdkpMTG5wS2VVTmN3Tnd1UDgyNEZkWE9QLWtJeS05dmpJeF9MR3hWMG5hRmt2aWc5Z29nWXE3Q2tzYlh5X19oLVBOTEQ2XzhfUDZ6SmZGUTNoZUR0SEdCWE1TWFFGdTgtUmc2LVFoTVJVTUIyRU5JM1pHaV9KSGN5OVcyYUg1dw?oc=5","date":"2024-08-26","type":"regulatory","source":"PR Newswire","summary":"Schizophrenia Market: RISVAN's Approval Has Sparked a Competitive Race Among Pharmaceutical Companies | DelveInsight - PR Newswire","headline":"Schizophrenia Market: RISVAN's Approval Has Sparked a Competitive Race Among Pharmaceutical Companies | DelveInsight","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNOUFJTF9pQjZkZHlEZm9lLS1NcnQ2eGRqbUhPMXVsalpHUHlLWGxFQWc0SEpDZ1hNQTVKODVKV2pEc3hwQ1FUS051NFhvbWF2LWQ2Ny1oTzh2clJLcFgzdGdhcF9LWDltLURfWWxpRE4wTm0xQ0UyWGNZcjVtT21vclY4R3Y2X3RvSXBsSVhxM29BTjQ3YllGMlpwN0V4a3J2ZlE0Mk5Da2U?oc=5","date":"2024-01-30","type":"deal","source":"BioWorld News","summary":"Travere licenses out rare kidney disease drug to Renalys in Asia - BioWorld News","headline":"Travere licenses out rare kidney disease drug to Renalys in Asia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPSWNaemZIbl85Z2NzOXM5M0lpR1gxdDhwaFJ0UWIyanMxbWxTTW9abFlJbWl6X3lBS0tvTGVGZWRtWTZOcDJ0YUt3cXc1enpYU0tiUkhGT0JiSFdzd1BRNGN6UDdMaTR1ZGVzNlJFeGFJX0hsSmU1V3VjS0lmV3Yza2VpLU5KaThScWtiTg?oc=5","date":"2023-09-01","type":"deal","source":"Pharmaceutical Technology","summary":"Otsuka Pharmaceutical agrees to buy Mindset Pharma - Pharmaceutical Technology","headline":"Otsuka Pharmaceutical agrees to buy Mindset Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBsNm1xWnRIM1BBLTlERWJyY1dVbkEzcVdJcjFCSHRZTGJDbVlNSVQtbk51SGhRVEtyUV9haFRYWUl3TVhiREMxMHhROXJ1YjVsN1BNcXJ6VDZ5Y3kzV25vQm02MlM2dzBpR01RQU1ubHJ0SG80STl3eTRMZw?oc=5","date":"2021-05-13","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Pharma’s top 20 R&D spenders in 2020 - drugdiscoverytrends.com","headline":"Pharma’s top 20 R&D spenders in 2020","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE5Ld1N2OUY0QjRqcjllWXVFakpZWlhFMkM4V2E3NVVzdjdtUWFLX01pQk1YalFWYmZrdWFqTlFjUEZoOUVCMFEtUVJPWFFfUXdKYjdxVm43MVlod0RHUVUxQ3RadF9jZHJH?oc=5","date":"2020-08-03","type":"pipeline","source":"Pharmaceutical Executive","summary":"Country Report: The Philippines - Pharmaceutical Executive","headline":"Country Report: The Philippines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9GdU5KVFZNUlZWQ0kzOFNDS0NOajV2MnV2UzRsUGJpOXVNVDg3UHM1dzR4RzVZUC02TERuOVFyLWlZdTh0eUhnNG5PTUlKbGh5d29BWW5kRElZTmRhVHhoczhqMVZoOTc3Wlh2eE1LaGlqbllvUDBUdQ?oc=5","date":"2018-05-23","type":"pipeline","source":"otsuka.co.jp","summary":"Otsuka Pharmaceutical Co.,Ltd. - otsuka.co.jp","headline":"Otsuka Pharmaceutical Co.,Ltd.","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}